NexLife vs Orderly Meds
How NexLife and Orderly Meds compare on price, medication type, clinical oversight, and pharmacy transparency — with the trade-offs and who each may suit.
| NexLife | Orderly Meds | |
|---|---|---|
| From / month | $186/mo* | Varies (verify) |
| Pricing model | Flat, dose-independent | Varies — see provider |
| Medication type | Compounded tirzepatide | Compounded |
| FDA status | Not FDA-approved (compounded) | Not FDA-approved |
| Clinical oversight | MD/DO-supervised | Telehealth clinician (verify) |
| Pharmacy / fulfillment | 503A & 503B (six disclosed) | Compounding pharmacy (verify) |
| What's included | Meds, visits, labs, coaching | Compounded medication via telehealth |
| Insurance | Cash-pay (HSA/FSA) | Cash-pay (verify) |
Pricing verified as of June 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.
Clinical model
NexLife uses MD/DO-supervised care with included lab review and titration support. Orderly Meds operates a telehealth clinician (verify) model (compounded). Eligibility and any prescription are determined by a licensed clinician in both cases, and outcomes are not guaranteed.
Pharmacy & fulfillment
NexLife discloses six partner pharmacies across the 503A and 503B pathways and offers certificates of analysis on request. Orderly Meds fulfillment: Compounding pharmacy (verify). Compounded products from either pathway are not FDA-approved — see 503A vs 503B.
Strengths and trade-offs
NexLife
- Flat, dose-independent pricing ($186/mo, 12-mo plan)
- MD/DO-supervised under a named Medical Director
- Six disclosed partner pharmacies (503A + 503B)
- Labs and Care360 coaching included; unlimited messaging
- LegitScript-certified
- Compounded only — not FDA-approved
- Cash-pay with HSA/FSA only — no insurance billing
- No brand-name Wegovy®/Zepbound®
- Results vary by patient; eligibility not guaranteed
Orderly Meds
- Compounded GLP-1 telehealth option
- Not FDA-approved (compounded)
- Verify model and pharmacy directly
- Pricing varies
Who each may be best for
NexLife may suit you if you want predictable flat pricing that doesn't rise with dose, MD/DO oversight, disclosed pharmacies, and bundled labs/coaching — and you're comfortable with compounded medication (not FDA-approved) paid cash-pay.
Orderly Meds may suit you if its specific model, pricing, or support style fits your needs — verify current details directly with the provider.
Questions
Is NexLife or Orderly Meds cheaper?
As of June 2026, NexLife starts at $186/month flat. Orderly Meds is listed from Varies (verify). Compare total annual cost including visits and labs, not just the headline price. Compounded tirzepatide is not FDA-approved. See NexLife pricing
What's the main difference between NexLife and Orderly Meds?
NexLife is flat-rate compounded tirzepatide with MD/DO oversight and disclosed 503A/503B pharmacies; Orderly Meds is compounded with a telehealth clinician (verify) model. Choose based on whether you want compounded vs brand, flat vs variable pricing, and your insurance situation.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.
Related comparisons & cost guides
Why this comparison is built to be trusted
Our editorial model separates low teaser pricing from all-in value. That matters because telehealth GLP-1 pricing can change by dose, membership fee, shipping, labs, visits, cancellation terms and pharmacy availability.
Total-cost scoring
Providers are compared by starting price signal, higher-dose pricing behavior, shipping, provider access, lab review, coaching/support and transparency.
Clear commercial disclosure
Some pages may contain commercial links. Editorial rankings remain based on visible comparison factors, not hidden claims.
Safety and verification
Readers are reminded to verify live pricing, state availability, pharmacy, prescription eligibility and whether compounded medication is appropriate with a licensed clinician.